Biodexa Pharmaceuticals Plc reported on May 23, 2025, that it posted its Annual Report for the year ended December 31, 2024, and distributed a Notice of Annual General Meeting scheduled for June 26, 2025, including proxy forms for shareholders. This filing is significant as it provides key company updates and governance information.